Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock

Critical Care Medicine

Volumn 32, Issue 6, 2004, Pages 1327-1331

  Malay, Mary Beth ^a   Ashton, Jennifer L ^a   Dahl, Katherine ^b   Savage, Edward B ^a   Burchell, Sherryl A ^a   Ashton Jr , Robert C ^a   Sciacca, Robert R ^b   Oliver, Juan A ^b   Landry, Donald W ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Endotoxic shock; Hypotension; Organ blood flow; Septic shock; Vascular resistance; Vasopressin

Indexed keywords

VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BRAIN PERFUSION; BREEDING; CAROTID ARTERY FLOW; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENETIC HETEROGENEITY; ILIAC ARTERY; INFUSION; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RANDOMIZATION; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SWINE; UNIVERSITY HOSPITAL; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CAROTID ARTERIES; CEREBROVASCULAR CIRCULATION; FEMALE; HEART RATE; ILIAC ARTERY; MESENTERIC ARTERIES; PHENYLEPHRINE; PULMONARY ARTERY; RENAL ARTERY; SHOCK, SEPTIC; SWINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 2942555025     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000128578.37822.F1     Document Type: Article

References (26)

1. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:1956-1958
2. Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
3. Landry DW, Levin HR, Gallant EM, et al: Vasopressin presser hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-1282
4. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
5. Malay MB, Ashton RCJ, Landry DW, et al: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-703
6. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487-493
7. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
8. Dünser MW, Mayr AJ, Ulmer H, et al: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant shock: A retrospective analysis. Anesth Analg 2001; 93:7-13
9. Wagner HN Jr, Brunwald E: The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 1956; 35:1412-1418
10. Sharshar T, Blanchard A, Paillard M, et al: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758
11. Landry DW, Oliver JA: Mechanisms of disease: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
12. Oliver JA, Landry DW: Patient with a sudden drop in blood pressure. Crit Care Med, 2003; 31:326-327
13. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120:989-1002
14. Klinzig S, Simon M, Reinhart K, et al: High dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31:2646-2650
15. Lambert M, de Peyer R, Muller AF: Reversible ischemic colitis after intravenous vasopressin therapy. JAMA 1982; 247:666-667
16. Shelly MP, Greatorex R, Calne RY, et al: The physiological effects of vasopressin when used to control intra-abdominal bleeding. Intensive Care Med 1998; 14:526-531
17. Anderson JR, Johnston GW: Development of cutaneous gangrene during continuous peripheral infusion of vasopressin. BMJ 1983; 287:1657-1658
18. Gogel HK, Sherman RW, Becker LE: Scrotal and abdominal skin necrosis complicating intravenous vasopressin therapy for bleeding esophageal varices. Dig Dis Sci 1985; 30:460-464
19. Slotnik IL, Teigland J: Cardiac accidents following vasopressin injection (Pitressin). JAMA 1951; 146:1126-1129
20. Beller BM, Trevino A, Urban E: Pitressin-induced myocardial injury and depression in a young woman. Am J Med 1971; 51:675-679
21. Schmid PG, Abboud FM, Wendling MG, et al: Regional vascular effects of vasopressin: Levels and circulatory responses. Am J Physiol 1974; 227:998-1004
22. Ericsson BF: Hemodynamic effects of vasopressin during haemorrhagic hypotension in the anesthetized dog. Acta Chir Scand 1972; 138:227-233
23. Breslow MJ, Miller CF, Parker SD, et al: Effect of vasopressors on organ blood flow during endotoxic shock in pigs. Am J Physiol 1987; 252:H291-H300
24. Gregory JS, Bonfiglio MF, Dasta JF, et al: Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19:1395-1400
25. Schwartz J, Reid IA: Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs. Endocrinology 1981; 109:1778-1780
26. Ebert TJ, Cowley AW Jr, Skelton M: Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man. J Clin Invest 1986; 77:1136-1142